Jason Aryeh's Net Worth

$5.94 Million

Estimate Recalculated Jul 2, 2025 11:05PM EST

Who is Jason Aryeh

Jason Aryeh has an estimated net worth of $5.94 Million. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, Myrexis, Inc., LIGAND PHARMACEUTICALS INC, NABI BIOPHARMACEUTICALS, QLT INC/BC, MERRIMACK PHARMACEUTICALS INC, Anebulo Pharmaceuticals, Inc., Aralez Pharmaceuticals Inc., and Orchestra BioMed Holdings, Inc..

SEC CIK

Jason Aryeh's CIK is 0001376960

Past Insider Trading and Trends

2023 was Jason Aryeh's most active year for acquiring shares with 11 total transactions. Jason Aryeh's most active month to acquire stocks was the month of May. 2015 was Jason Aryeh's most active year for disposing of shares, totalling 4 transactions. Jason Aryeh's most active month to dispose stocks was the month of May. 2016 saw Jason Aryeh paying a total of $1,999,998.88 for 1,281,263 shares, this is the most they've acquired in one year. In 2010 Jason Aryeh cashed out on 17,000 shares for a total of $97,580.00, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNOMEDICS INC

Investor

Updated Jan 10, 2017


Form 4	—	22.50K	—	—	Jan 10, 2017	22.50K	Grant	—	Jan 08
Form 3	—	—	—	—	Jan 10, 2017	—	—	—	—

Showing 2 results

Myrexis, Inc.

Investor

Updated Jun 20, 2012


Form 4	0.55%	3.00K	$2.29	$6.88K	Jun 20, 2012	555.15K	Purchase	—	Jun 18
Form 4	0.94%	5.03K	$2.36	$11.86K	Jun 18, 2012	552.15K	Purchase	—	Jun 14 - Jun 15
Form 4	0.21%	1.12K	$2.40	$2.67K	Jun 11, 2012	547.12K	Purchase	—	Jun 07
Form 4	2.71%	14.15K	$2.38	$33.68K	Jun 01, 2012	546.00K	Purchase	—	May 30 - May 31
Form 4	0.22%	1.15K	$2.47	$2.85K	May 25, 2012	531.85K	Purchase	—	May 23 - May 25
Form 4	2.41%	12.26K	$2.50	$30.70K	May 23, 2012	530.70K	Purchase	—	May 21 - May 22
Form 4	2.21%	11.00K	$2.60	$28.62K	May 21, 2012	518.44K	Purchase	—	May 17 - May 18
Form 4	0.40%	1.96K	$5.00	$10.00K	Mar 20, 2012	507.44K	Options	—	Mar 17
Form 4	1.93%	9.40K	$5.00	$47.50K	Feb 01, 2012	505.44K	Options	—	Jan 31
Form 4	5.37%	24.75K	$5.30	$132.50K	Dec 20, 2011	495.94K	Options	—	Dec 17
Form 4	7.16%	30.79K	$2.75	$84.80K	Dec 06, 2011	470.94K	Purchase	—	Dec 05
Form 4	19.50%	70.22K	$2.67	$187.19K	Dec 05, 2011	440.14K	Purchase	—	Dec 01 - Dec 02
Form 4	37.92%	101.70K	$2.60	$262.45K	Dec 01, 2011	369.93K	Purchase	—	Nov 29 - Nov 30
Form 4	66.12%	106.76K	$2.54	$270.78K	Nov 29, 2011	268.23K	Purchase	—	Nov 25 - Nov 28
Form 4	96.27%	79.20K	$2.48	$196.26K	Nov 25, 2011	161.47K	Purchase	—	Nov 22 - Nov 23
Form 4	1.22%	990.00	$7.50	$7.50K	Nov 22, 2011	82.27K	Options	—	Nov 19
Form 4	17.66%	12.20K	$2.64	$32.24K	Nov 15, 2011	81.27K	Purchase	—	Nov 11 - Nov 14
Form 4	1.74%	1.19K	$5.00	$6.00K	Nov 07, 2011	69.29K	Options	—	Nov 03
Form 4	—	25.00K	—	—	Oct 21, 2011	25.00K	Grant	—	Oct 19
Form 3	—	—	—	—	Oct 21, 2011	67.87K	—	—	—

Showing 20 results

LIGAND PHARMACEUTICALS INC

Investor

Updated Jun 18, 2024

View Quote Details


Form 4	8.72%	6.70K	—	—	Jun 18, 2024	140.14K	Grant	—	Jun 14
Form 4	—	—	$52.30	$125.83K	May 02, 2024	133.45K	Options	—	Apr 30
Form 4	—	—	$39.35	$113.84K	Mar 06, 2024	131.04K	Options	—	Mar 05
Form 4	9.38%	6.60K	—	—	Jun 13, 2023	133.61K	Grant	—	Jun 09
Form 4	—	4.48K	—	—	Dec 27, 2022	4.48K	Grant	—	Dec 22
Form 4	7.78%	5.34K	—	—	Jun 13, 2022	130.63K	Grant	—	Jun 10
Form 4/A	—	2.47K	—	—	Jul 03, 2018	2.47K	Grant	—	Jun 19
Form 4/A	16.84%	5.00K	—	—	Jun 08, 2007	34.70K	Grant	—	May 31
Form 3/A	—	—	—	—	Oct 19, 2006	34.15K	—	—	—
Form 3	—	—	—	—	Oct 05, 2006	1.60M	—	—	—

Showing 10 results

NABI BIOPHARMACEUTICALS

Investor

Updated May 27, 2011

View Quote Details


Form 4	—	20.00K	—	—	May 27, 2011	20.00K	Grant	—	May 25
Form 4	-3.58%	-4.90K	$5.87	-$28.76K	Mar 17, 2011	131.78K	Sale	—	Mar 15
Form 4	-2.43%	-3.40K	$5.83	-$19.83K	Mar 16, 2011	136.68K	Sale	—	Mar 14
Form 4	-14.99%	-24.70K	$5.76	-$142.17K	Mar 15, 2011	140.08K	Sale	—	Mar 11
Form 4	-100.00%	-15.09K	$5.74	-$86.63K	Dec 29, 2010	164.78K	Sale	—	Dec 27
Form 4/A	-11.22%	-1.91K	$5.74	-$10.95K	Dec 29, 2010	179.88K	Sale	—	Dec 15
Form 4	-1.05%	-1.91K	$5.74	-$10.95K	Dec 17, 2010	179.88K	Sale	—	Dec 15
Form 4	-2.52%	-4.71K	$5.49	-$25.83K	Dec 10, 2010	181.78K	Sale	—	Dec 08
Form 4	-3.47%	-6.70K	$5.53	-$37.05K	Dec 03, 2010	186.49K	Sale	—	Dec 01
Form 4	-4.07%	-8.20K	$5.24	-$42.97K	Nov 22, 2010	193.19K	Sale	—	Nov 18 - Nov 22
Form 4	-2.38%	-4.90K	$5.30	-$25.97K	Nov 15, 2010	201.38K	Sale	—	Nov 11
Form 4	-7.86%	-17.60K	$5.35	-$94.08K	Nov 12, 2010	206.28K	Sale	—	Nov 09 - Nov 10
Form 4	-8.42%	-20.57K	$5.00	-$102.95K	Oct 20, 2010	223.88K	Sale	—	Oct 18 - Oct 20
Form 4	-1.78%	-4.42K	$5.00	-$22.11K	Oct 13, 2010	244.46K	Sale	—	Oct 11
Form 4	-0.24%	-600.00	$5.74	-$3.45K	Aug 19, 2010	248.88K	Sale	—	Jun 11
Form 4	-0.85%	-2.15K	$5.74	-$12.32K	Jun 15, 2010	249.48K	Sale	—	Jun 11
Form 4	-0.10%	-258.00	$5.81	-$1.50K	Jun 07, 2010	251.63K	Sale	—	Jun 03
Form 4	—	20.00K	—	—	May 25, 2010	20.00K	Grant	—	May 20
Form 4	-20.52%	-65.03K	$6.25	-$406.29K	Mar 26, 2010	251.88K	Sale	Scheduled	Mar 23 - Mar 24
Form 4	-8.25%	-28.51K	$6.24	-$177.90K	Mar 24, 2010	316.91K	Sale	Scheduled	Mar 22
Form 4	-2.21%	-7.80K	$5.99	-$46.72K	Mar 23, 2010	345.42K	Sale	—	Mar 19
Form 4/A	—	—	—	—	Mar 23, 2010	371.42K	—	—	—
Form 4	-1.83%	-6.58K	$5.96	-$39.22K	Mar 22, 2010	352.62K	Sale	—	Mar 18
Form 4	-3.08%	-11.42K	$5.94	-$67.88K	Mar 19, 2010	359.20K	Sale	—	Mar 17
Form 4	-0.05%	-200.00	$5.93	-$1.19K	Mar 17, 2010	370.62K	Sale	—	Mar 15
Form 4	-4.28%	-16.60K	$5.93	-$98.37K	Mar 16, 2010	370.82K	Sale	—	Mar 12
Form 4	-31.81%	-180.70K	$5.88	-$1.06M	Mar 15, 2010	387.42K	Sale	Scheduled	Mar 11
Form 4	-2.76%	-16.10K	$5.74	-$92.41K	Mar 12, 2010	568.12K	Sale	Scheduled	Mar 10
Form 4	-0.54%	-3.20K	$5.75	-$18.39K	Mar 10, 2010	584.22K	Sale	Scheduled	Mar 08
Form 4	-2.30%	-13.80K	$5.49	-$75.77K	Jan 15, 2010	587.42K	Sale	Scheduled	Jan 13
Form 4	-12.54%	-86.20K	$5.49	-$473.37K	Jan 14, 2010	601.22K	Sale	Scheduled	Jan 12
Form 4	-11.80%	-91.97K	$5.27	-$484.54K	Jan 08, 2010	687.42K	Sale	Scheduled	Jan 06 - Jan 08
Form 4	-1.02%	-8.04K	$5.24	-$42.10K	Dec 23, 2009	779.39K	Sale	—	Dec 22
Form 4	-0.51%	-4.04K	$5.24	-$21.20K	Dec 18, 2009	787.42K	Sale	—	Dec 16
Form 4	-19.02%	-185.91K	$5.07	-$941.93K	Nov 18, 2009	791.47K	Sale	—	Nov 17
Form 4	-19.60%	-238.28K	$4.51	-$1.15M	Nov 18, 2009	977.37K	Sale	—	Sep 15 - Nov 16
Form 4	—	20.00K	—	—	May 27, 2009	20.00K	Grant	—	May 22
Form 4	—	20.00K	—	—	Jun 09, 2008	20.00K	Grant	—	May 07
Form 4	—	20.00K	—	—	May 22, 2007	20.00K	Grant	—	May 18
Form 4	—	18.00K	—	—	Nov 14, 2006	18.00K	Grant	—	Nov 10
Form 3	—	—	—	—	Oct 30, 2006	1.23M	—	—	—

Showing 41 results

NOVELION THERAPEUTICS INC.

Investor

Updated May 17, 2017


Form 4	0.15%	361.00	$8.95	$3.23K	May 17, 2017	392.73K	Purchase	—	May 15
Form 4	—	9.60K	—	—	Dec 27, 2016	9.60K	Grant	—	Dec 22
Form 4	266.38%	1.43M	$1.76	$2.00M	Dec 01, 2016	1.96M	Grant	—	Nov 29
Form 4	256.36%	112.80K	—	—	Jun 21, 2016	156.80K	Grant	—	Jun 17
Form 4	4.15%	18.40K	$2.50	$46.00K	Dec 30, 2015	535.48K	Purchase	—	Dec 29
Form 4	—	—	$3.46	$172.75K	Jul 01, 2015	517.08K	Options	—	Jun 30
Form 4	—	288.00K	$3.47	$999.36K	Jun 18, 2015	467.08K	Purchase	—	Jun 16
Form 4	—	—	—	—	Jun 09, 2015	179.08K	Options	—	Jun 07
Form 4	—	37.00K	—	—	Dec 19, 2014	37.00K	Grant	—	Dec 17
Form 4	—	—	—	—	Dec 17, 2014	12.00K	Options	—	Dec 15
Form 4	—	59.00K	—	—	Jul 17, 2013	59.00K	Grant	—	Jul 15
Form 4/A	-8.40%	-34.00	$40.00	-$1.36K	Jun 07, 2013	371.00	Sale	—	Jun 04
Form 4	-8.40%	-34.00	$40.00	-$1.36K	Jun 06, 2013	371.00	Sale	—	Jun 04
Form 4	-12.92%	-50.00	$40.00	-$2.00K	May 28, 2013	337.00	Sale	—	May 24
Form 4	-29.00%	-87.00	$40.00	-$3.48K	May 21, 2013	287.00	Sale	—	May 17
Form 4	-100.00%	-200.00	$0.43	-$85.00	May 07, 2013	200.00	Sale	—	May 03
Form 4	-100.00%	-455.00	—	—	Dec 26, 2012	—	Options	—	Dec 22
Form 4	—	—	$10.00	$5.00K	Oct 15, 2012	155.08K	Options	—	Oct 11
Form 4	0.49%	760.00	$10.00	$10.00K	Sep 25, 2012	154.58K	Options	—	Sep 22
Form 4	—	22.00K	—	—	Jul 12, 2012	22.00K	Grant	—	Jul 10
Form 4	1.32%	2.01K	$10.00	$25.00K	Jun 19, 2012	153.58K	Options	—	Jun 16
Form 3	—	—	—	—	Jun 13, 2012	151.08K	—	—	—

Showing 22 results

MERRIMACK PHARMACEUTICALS INC

Investor

Updated Jul 18, 2019

View Quote Details


Form 4	8.63%	302.00	$5.44	$1.64K	Jul 18, 2019	3.80K	Purchase	—	Jul 16
Form 4	—	3.50K	$5.68	$19.90K	Jul 15, 2019	3.50K	Purchase	—	Jul 11 - Jul 12
Form 3	—	—	—	—	Mar 20, 2019	—	—	—	—

Showing 3 results

Anebulo Pharmaceuticals, Inc.

Investor

Updated Jun 17, 2024

View Quote Details


Form 4	—	44.15K	—	—	Jun 17, 2024	44.15K	Grant	—	Jun 13
Form 4	—	30.43K	—	—	Oct 03, 2022	30.43K	Grant	—	Apr 21
Form 3	—	—	—	—	May 06, 2021	—	—	—	—

Showing 3 results

Aralez Pharmaceuticals Inc.

Investor

Updated May 24, 2017


Form 4	-100.00%	-388.69K	$1.44	-$558.80K	May 24, 2017	15.00K	Sale	—	May 19 - May 23
Form 4	300.00%	22.50K	—	—	May 12, 2017	373.22K	Grant	—	May 11
Form 4	625.81%	295.93K	$5.86	$1.73M	Apr 25, 2017	350.72K	Purchase	—	Sep 16
Form 4	—	22.50K	—	—	Jun 20, 2016	69.79K	Grant	—	Jun 16
Form 3	—	—	—	—	Feb 05, 2016	47.29K	—	—	—

Showing 5 results

Orchestra BioMed Holdings, Inc.

Investor

Updated Jun 21, 2024

View Quote Details


Form 4	35.63%	22.44K	—	—	Jun 21, 2024	85.43K	Grant	—	Jun 20
Form 4	—	25.00K	—	—	Jul 24, 2023	25.00K	Grant	—	Jul 20
Form 4/A	—	23.25K	—	—	May 19, 2023	23.25K	Grant	—	Jan 26
Form 4	43.47%	22.49K	—	—	May 05, 2023	74.23K	Options	—	Apr 12
Form 4/A	—	22.49K	—	—	May 05, 2023	22.49K	Grant	—	Jan 26
Form 4	—	100.56K	—	—	Jan 30, 2023	100.56K	Grant	—	Jan 26
Form 3	—	—	—	—	Jan 30, 2023	—	—	—	—

Showing 7 results